Spok Holdings, Inc. (SPOK)
NASDAQ: SPOK · IEX Real-Time Price · USD
15.27
+0.35 (2.35%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Spok Holdings Revenue

Spok Holdings had revenue of $140.75M in the twelve months ending March 31, 2024, with 5.13% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $34.91M with 5.21% year-over-year growth. In the year 2023, Spok Holdings had annual revenue of $139.03M with 3.34% growth.

Revenue (ttm)
$140.75M
Revenue Growth
+5.13%
P/S Ratio
2.20
Revenue / Employee
$359,064
Employees
392
Market Cap
309.15M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023139.03M4.49M3.34%
Dec 31, 2022134.53M-7.62M-5.36%
Dec 31, 2021142.15M-6.03M-4.07%
Dec 31, 2020148.18M-12.11M-7.55%
Dec 31, 2019160.29M-9.19M-5.42%
Dec 31, 2018169.47M-1.70M-0.99%
Dec 31, 2017171.18M-8.39M-4.67%
Dec 31, 2016179.56M-10.07M-5.31%
Dec 31, 2015189.63M-10.65M-5.32%
Dec 31, 2014200.27M-9.48M-4.52%
Dec 31, 2013209.75M-9.94M-4.53%
Dec 31, 2012219.70M-14.00M-5.99%
Dec 31, 2011233.69M439.00K0.19%
Dec 31, 2010233.25M-56.45M-19.49%
Dec 31, 2009289.71M-69.74M-19.40%
Dec 31, 2008359.45M-65.18M-15.35%
Dec 31, 2007424.62M-73.07M-14.68%
Dec 31, 2006497.69M-120.88M-19.54%
Dec 31, 2005618.57M128.41M26.20%
Dec 31, 2004490.16M-107.32M-17.96%
Dec 31, 2003597.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 430.75M
Cerus 191.72M
Vanda Pharmaceuticals 177.60M
Xeris Biopharma Holdings 171.36M
AxoGen 163.73M
Sight Sciences 81.50M
C4 Therapeutics 20.04M
Verrica Pharmaceuticals 8.91M
Revenue Rankings